CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

BioCardia to Support Development of Potential Cell Therapy Products

BioCardia to Support Development of...

ProPhase Labs Expects Business Expansion with Key Promotions and Addition to Management Team

ProPhase Labs Expects Business...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

BioCardia to Support Development of Potential Cell Therapy Products

BioCardia to Support Development of...

ProPhase Labs Expects Business Expansion with Key Promotions and Addition to Management Team

ProPhase Labs Expects Business...

Jounce Therapeutics Welcomes Jigar Raythatha to its Board of Directors

Life Sciences Review Life Sciences Review | Thursday, September 30, 2021
Tweet

Jigar Raythatha, former Chief Executive Officer of Constellation Pharmaceuticals and former Jounce Chief Business Officer, has been appointed to the board of directors of Jounce Therapeutics.


FREMONT, CA: Jigar Raythatha, former Chief Executive Officer of Constellation Pharmaceuticals and Jounce Chief Business Officer, has been appointed to the board of directors of Jounce Therapeutics, Inc., a clinical-stage organization centered on the discovery and development of novel cancer immunotherapy's and predictive biomarkers.


 "It's incredibly exciting to welcome Jigar to our board of directors. Not only does Jigar bring over 20 years of biotechnology industry experience, but he also comes with a unique position as an early employee of the company at its inception," said Richard Murray, Ph.D., chief executive officer and president of Jounce Therapeutics. "Jigars leadership and business development expertise will enhance our board's diversified perspective. He was an integral part of creating the Jounce we know today, and we all look forward to collaborating with him once again."


"Over the course of the last several years, Jounce has established a strong position as a leader in novel immuno-oncology drug discovery, and I am thrilled to join the board at this time in the companys life cycle. 


Jounces recent growth, pipeline diversification and partnership strategy are core to its track record as a leader in transforming the immuno-oncology landscape," said Jigar Raythatha. "I look forward to providing insights from my prior experience with the company, coupled with my perspective as a former chief executive officer in the biotechnology industry."


In addition to Mr. Raythathas's appointment, Jounce also stated that Cary Pfeffer, M.D., a partner at Third Rock Ventures, a founding board member, and former interim chief executive officer, will retire from the Jounce board, effective December 31, 2021. Dr. Pfeffer has been a member of Jounce's board of directors since its inception in 2013 and served as its chair from 2014 to 2016.


 "On behalf of the Jounce Board of Directors, I want to thank Cary for his years of dedication to Jounces science, team and mission," said Perry Karsen, chair of the Board of Jounce Therapeutics. "Cary's initial vision, his continuous guidance, and his unwavering support were invaluable to the creation and development of Jounces Translational Science Platform, helping us furthers our goal of matching the right immunotherapy to the right patients for meaningful and long-lasting therapeutic benefit."


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing
Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/jounce-therapeutics-welcomes-jigar-raythatha-to-its-board-of-directors-nwid-578.html